Retraction: MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation (PLoS ONE (2013) 8:4 (e60369) DOI: 10.1371/journal.pone.0060369);MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lei, Huizi ^a,b   Zou, Dongling ^b,c   Li, Zheng ^d   Luo, Min ^b   Dong, Lei ^b   Wang, Bin ^b   Yin, Haixin ^b   Ma, Yanni ^b   Liu, Changzheng ^b   Wang, Fang ^b   Zhang, Junwu ^b   Yu, Jia ^b   Li, Yu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c Chongqing Cancer Institute   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MICRORNA; MICRORNA 219 2 3P; MITOGEN ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR SOX4; TRICHOSTATIN A; UNCLASSIFIED DRUG; MIRN219 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROMOTER REGION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; UPREGULATION; AGED; BIOLOGY; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COMPUTATIONAL BIOLOGY; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS;

EID: 84876581773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0282980     Document Type: Erratum

References (37)

1. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3Article3.
2. Yasui W, Oue N, Sentani K, Sakamoto N, Motoshita J, (2009) Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol Int 59: 121-136.
3. Zambon CF, Basso D, Navaglia F, Falda A, Belluco C, et al. (2004) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 126: 382-384.
4. Sawaki A, Ohashi Y, Omuro Y, Satoh T, Hamamoto Y, et al. (2012) Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer 15: 313-322.
5. Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, et al. (2011) Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29: 3968-3976.
6. Tomari Y, Zamore PD, (2005) Perspective: machines for RNAi. Genes Dev 19: 517-529.
7. Engels BM, Hutvagner G, (2006) Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25: 6163-6169.
8. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, et al. (2008) Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170.
9. Calin GA, Croce CM, (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394.
10. Lujambio A, Esteller M, (2007) CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6: 1455-1459.
11. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP, (2003) Vertebrate microRNA genes. Science 299: 1540.
12. Rao SA, Santosh V, Somasundaram K, (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23: 1404-1417.
13. Huang N, Lin J, Ruan J, Su N, Qing R, et al. (2012) MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett 586: 884-891.
14. Andolfo I, Liguori L, De Antonellis P, Cusanelli E, Marinaro F, et al. (2012) The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol 14: 596-612.
15. de Faria O Jr, Cui QL, Bin JM, Bull SJ, Kennedy TE, et al. (2012) Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes. Front Genet 3: 46.
16. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
17. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J, (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105.
18. Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, et al. (2010) miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 127: 1363-1372.
19. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, et al. (2011) MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 32: 772-778.
20. Shen XJ, Wang HB, Ma XQ, Chen JH, (2012) beta,beta-Dimethylacrylshikonin induces mitochondria dependent apoptosis through ERK pathway in human gastric cancer SGC-7901 cells. PLoS One 7: e41773.
21. Kohno M, Pouyssegur J, (2006) Targeting the ERK signaling pathway in cancer therapy. Ann Med 38: 200-211.
22. Pinhel IF, Macneill FA, Hills MJ, Salter J, Detre S, et al. (2010) Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res 12: R76.
23. Park S, Jung HH, Park YH, Ahn JS, Im YH, (2011) ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression. Biochem Biophys Res Commun 407: 680-686.
24. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, et al. (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
25. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, et al. (2008) Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
26. Rodriguez-Paredes M, Esteller M, (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330-339.
27. Sharma S, Kelly TK, Jones PA, (2010) Epigenetics in cancer. Carcinogenesis 31: 27-36.
28. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
29. Wu JH, Gao Y, Ren AJ, Zhao SH, Zhong M, et al. (2012) Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic Res 47: 195-201.
30. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT, (2011) Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121: 193-205.
31. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, et al. (2008) Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 216: 471-482.
32. Hayashi M, Inokuchi M, Takagi Y, Yamada H, Kojima K, et al. (2008) High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res 14: 7843-7849.
33. Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, et al. (2011) Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. J Clin Oncol 29: 3030-3036.
34. Rojo F, Tabernero J, Albanell J, Van Cutsem E, Ohtsu A, et al. (2006) Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma. J Clin Oncol 24: 4309-4316.
35. Engelman JA, Janne PA, Mermel C, Pearlberg J, Mukohara T, et al. (2005) ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proc Natl Acad Sci U S A 102: 3788-3793.
36. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, et al. (2007) Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282: 1479-1486.
37. Wurdinger T, Costa FF, (2007) Molecular therapy in the microRNA era. Pharmacogenomics J 7: 297-304.